Type 2 DiabetesARRANCT06145542
Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
A study testing AR group: aerobic training before resistance training and RA group: resistance exercise before aerobic exercise in people with Type 2 Diabetes, run by Zhejiang University at 1 site in China.
Trial summary
Aerobic exercise and resistance exercise are two types of exercise commonly used in physical conditioning. Compared to aerobic exercise, a combination of aerobic and resistance exercise has been linked to a greater reduction in hemoglobin A1c (HbA1c) among patients with type 2 diabetes (T2D). Read more about this study
- Who is it for?
- Ages 50 to 70 years
- Conditions the study is for
- Type 2 Diabetes
- What is being tested?
- AR group: aerobic training before resistance training and RA group: resistance exercise before aerobic exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 56 participants
- Where
- 1 siteChina
- Study dates
- 25 Sep 2023to 2 Jul 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 50-70 years;
- Type 2 diabetes diagnosed as: random blood glucose ≥11.1mmol/L (200mg/dL) or fasting blood glucose ≥7.0mmol/L (126mg/L) or oral glucose tolerance test (2h) ≥11.1mmol/L (200mg/dL) or glycated hemoglobin (HbA1c) ≥ 6.5%;
- The course of type 2 diabetes lasted for one year or longer;
- Willing to participate and sign the informed consent form voluntarily
Who cannot join
- Type 1 diabetes;
- Fasting blood glucose (FBG)>16.7mmol/L;
- Severe complications of diabetes such as acute infection, diabetic ketoacidosis, and plantar lesions;
- Severe kidney disease, cardiovascular and cerebrovascular diseases as identified by a specialist;
- Musculoskeletal, neurological, psychiatric or other disorders which limit the ability to exercise as identified by a specialist;
- Doing physical exercise regularly (≥ 3 times per week, at least 1 hour per session of moderate to vigorous activities);
Show all 10Show fewer
- Currently under dietary program for weight loss;
- Systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥100 mmHg at rest;
- Abnormal electrocardiogram (rest and exercise);
- Other comorbidities or medications irrelevant to diabetes treatment that may influence glycemia during the past 6 months
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sequences of Aerobic and Resistance Exercise in Training and Their Effects on Cardio-metabolic Functions Among Type 2 Diabetes Patients - a Randomized Study
Aerobic exercise and resistance exercise are two types of exercise commonly used in physical conditioning. Compared to aerobic exercise, a combination of aerobic and resistance exercise has been linked to a greater reduction in hemoglobin A1c (HbA1c) among patients with type 2 diabetes (T2D). However, it is not clear that in a concurrent aerobic-resistance training session, whether the orders of the two types of exercise could act differently in glucose metabolism. This randomized trial aims to investigate the effect of the sequence of exercise modalities (aerobic-resistance vs resistance-aerobic in a training session) on glycemic control among T2D patients following an 8-wk intervention period.
Read the detailed description
Objectives:
This randomized study aims to explore the effects of aerobic and resistance training sequences on glycemic control among type 2 diabetes (T2D) patients through an 8-wk combined aerobic and resistance exercise training program.
Study Population:
A total of 56 participants with T2D aged 50-70 years (sex ratio approximately 1:1) with a course of type 2 diabetes of more than one year are included. Participants are residents of Nanjing Municipality, Jiangsu Province, China. Participants are recruited from the outpatients at Maigaoqiao Community Health Service Center, Qixia District, Nanjing, China or through online advertisement published on the official social media (WeChat) channels of the Health Service Center.
Randomization:
Participants are stratified by baseline hemoglobin A1c (HbA1c) and age, they are randomly assigned into two groups with a block size of 4. The study groups are: 1) aerobic before resistance training (AR group, n=28); 2) resistance before aerobic training (RA group, n=28).
Exercises intervention program:
Exercised program is designed to take place three times a week for a total of eight weeks. Exercise intervention is scheduled for approximately 70 minutes per session (30 minutes of aerobic and 30 minutes of resistance, no break between two types, 5-min of preparation and 5-min relaxation stretching movements before and after each intervention), performed between 8:00 to 11:00 or between 14:00 to 16:30, Monday through Saturday.
Target heart rate during aerobic exercise is set as resting heart rate (HR) + 40%-70% of heart rate reserve (HRR). Participants' HRR was calculated based on their resting HR and maximum heart rate (HRmax=208-0.7×age) as HRmax - HR. Heart rate monitors (OH1, Polar Oy, Oulu, Finland) are used during all exercise sessions to track exercise intensity and ensure that it remained within the specified range. Aerobic exercise is performed on bicycle ergometers for a continuous 30 minutes with a progressive intensity of 40%-70% HRR. Resistance level is set according to an adaptive training prior to the first intervention, pedal cadences are 50-60r/min.
Resistance exercise is conducted using a set of equipment including chest press/ row, leg extension/ curl, abdominal/ back, biceps/ triceps, inner/ outer thigh, and push/ pull machines. Prior to conducting the 1 repetition maximum (RM) testing for the major muscles of the upper and lower limbs, all participants receive proper instructions on how to use the equipment. The Brzycki 1-RM prediction equation is used to estimate the 1RM based on the recorded resistance and repetitions. All participants performe resistance exercise with a weight of 60%-80% 1RM. Movements on each machine are repeated 10-12 times per unit for a total of 4 units, with a-30 second break between units.
In all intervention sessions, participants in AR group complete aerobic exercise before starting resistance exercise, while participants in RA group performe two types of exercise in a reversed order. Participants are instructed to maintain their usual lifestyle but refrain from engaging in other forms of regular exercise throughout the intervention period.
- Conditions
- Type 2 Diabetes
- Being tested
- AR group: aerobic training before resistance training, RA group: resistance exercise before aerobic exercise
- Keywords
- aerobic exercise, resistance exercise, exercise order, glycemic control
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AR group: aerobic training before resistance trainingBehavioural
Exercise are performed 3 times/wk for 8 wks.
Aerobic training sessions are performed using cycle ergometers. Riding speed is 55-60 rotations/min, at an intensity between 50%-75% of heart rate reserve (HRR). Real-time heart rate monitors are worn by each participant during the session. Aerobic training session lasts for 30 minutes, with an additional 5-minute warm-up and 5-min relaxation training before and after the session, respectively.
Participants perform resistance exercise on a set of strength training equipment. Load of resistance exercise is between 60-80% of repetition maximum (RM) in each set of exercise. Six different groups of resistance exercise (involving contractions and relaxations of biceps, triceps, pectoralis major, latissimus dorsi, quadriceps, and hamstrings) are conducted, with 6 sets of 10 repeated tasks in each group. Participants are instructed to finish each set of exercise task within 60 seconds. Between each two sets, there are 60 s of rest time.
RA group: resistance exercise before aerobic exerciseBehavioural
Exercise are performed 3 times/wk for 8 wks.
Following a 5-min warm-up exercise, the participants perform resistance training on a set of equipment. Load of resistance exercise is set between 60-80% of repetition maximum in each set of exercise. Six different groups of resistance exercise (involving contractions and relaxations of biceps, triceps, pectoralis major, latissimus dorsi, quadriceps, and hamstrings) are conducted, with 6 sets of 10 repeated tasks in each group. Participants are instructed to finish each set of exercise task within 60 s. Between each two sets, there are 60 seconds of rest time.
Aerobic training sessions are performed using cycle ergometers. Riding speed is 55-60 rotations/min, at an intensity between 50%-75% of heart rate reserve. Real-time heart rate monitors are worn during the entire session. Each aerobic training session lasts for 30 minutes, with an 5-minute relaxation training after the session.
| Study group | Role | What they receive |
|---|---|---|
| AR group | Experimental | aerobic exercise then resistance exercise in all training sessions Receives: Behavioral: AR group: aerobic training before resistance training |
| RA group | Active comparator | resistance exercise then aerobic exercise in all training sessions Receives: Behavioral: RA group: resistance exercise before aerobic exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fasting Glucose at Baseline
blood glucose level following overnight (12-h) fasting
Measured: At week 0, within 7 days before the intervention starts
Fasting Glucose at Follow-up
blood glucose level following overnight (12-h) fasting
Measured: At week 9, within 7 days after the intervention completes
Hemoglobin A1c (HbA1c) at Baseline
At baseline, the HbA1c level in blood among all participants
Measured: At baseline, within 7 days before the intervention starts
Hemoglobin A1c (HbA1c) at Follow-up
After intervention, the HbA1c level in blood among all participants
Measured: At week 9, within 7 days after the completion of the 8-week intervention
Continuous Glucose Monitoring at Baseline (Mean, sd, Lage)
At baseline, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Measured: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (mean, sd, lage)
Continuous Glucose Monitoring at Baseline (Coefficient of Variation)
At baseline, 14-day continuous glucose monitoring including mean glucose value, standard deviation (SD) of the glucose values, coefficient of variation (CV) of relative standard deviation, LAGE, TIR, TAR, TBR
Measured: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (cv)
Continuous Glucose Monitoring at Baseline (Tir, Tar, Tbr)
At baseline, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Measured: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (tir, tar, tbr)
Continuous Glucose Monitoring at Follow-up (Mean, sd, Lage)
After intervention, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Measured: at week 8-9
Continuous Glucose Monitoring at Follow-up (Coefficient of Variation)
At baseline, 14-day continuous glucose monitoring including mean glucose value, standard deviation (SD) of the glucose values, coefficient of variation (CV) of relative standard deviation, LAGE, TIR, TAR, TBR
Measured: at week 8-9
Continuous Glucose Monitoring at Follow-up (Tir, Tar, Tbr)
After intervention, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Measured: at week 8-9
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2023
- Study start25 Sep 2023
- Primary completion2 Feb 2024
- Study completion2 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Type 2 DiabetesStudies of the same condition, open and under way.
- More trials run by Zhejiang UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Zhejiang University
- Sponsor type
- University, hospital or other
- Collaborators
- Nanjing Sport Institute, Karolinska Institutet
- Responsible party
- Principal investigator, Xiao Tan, Zhejiang University
- Investigators
- Yan Zhao, MD, PhD, Study director, Nanjing Sport InstituteXiao Tan, PhD, Principal investigator, Zhejiang UniversityLijun Wei, MD, Study director, Maigaoqiao Community Health Service Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06145542
- Sponsor's protocol ID
- RT-2023-17
- Acronym
- ARRA
- Status last verified
- Apr 2025
- First submitted
- 17 Nov 2023
- Last updated
- 3 Apr 2025
- Results posted
- Yes, on ClinicalTrials.gov
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sequences of Aerobic and Resistance Exercise in Training and Their Effects on Cardio-metabolic Functions Among Type 2 Diabetes Patients - a Randomized Study
- ClinicalTrials.gov ID
- NCT06145542
- Acronym / sponsor ID
- ARRA / RT-2023-17
- Conditions
- Type 2 Diabetes
- Keywords
- aerobic exercise, resistance exercise, exercise order, glycemic control
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Zhejiang UniversityUniversity, hospital or other
- Collaborators
- Nanjing Sport Institute, Karolinska Institutet
- Study start
- 25 Sep 2023 (actual)
- Primary completion
- 2 Feb 2024 (actual)
- Study completion
- 2 Jul 2024 (actual)
- First posted
- 24 Nov 2023 (actual)
- Results
- Posted 3 Apr 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aerobic exercise and resistance exercise are two types of exercise commonly used in physical conditioning. Compared to aerobic exercise, a combination of aerobic and resistance exercise has been linked to a greater reduction in hemoglobin A1c (HbA1c) among patients with type 2 diabetes (T2D). However, it is not clear that in a concurrent aerobic-resistance training session, whether the orders of the two types of exercise could act differently in glucose metabolism. This randomized trial aims to investigate the effect of the sequence of exercise modalities (aerobic-resistance vs resistance-aerobic in a training session) on glycemic control among T2D patients following an 8-wk intervention period.
Detailed description
Objectives:
This randomized study aims to explore the effects of aerobic and resistance training sequences on glycemic control among type 2 diabetes (T2D) patients through an 8-wk combined aerobic and resistance exercise training program.
Study Population:
A total of 56 participants with T2D aged 50-70 years (sex ratio approximately 1:1) with a course of type 2 diabetes of more than one year are included. Participants are residents of Nanjing Municipality, Jiangsu Province, China. Participants are recruited from the outpatients at Maigaoqiao Community Health Service Center, Qixia District, Nanjing, China or through online advertisement published on the official social media (WeChat) channels of the Health Service Center.
Randomization:
Participants are stratified by baseline hemoglobin A1c (HbA1c) and age, they are randomly assigned into two groups with a block size of 4. The study groups are: 1) aerobic before resistance training (AR group, n=28); 2) resistance before aerobic training (RA group, n=28).
Exercises intervention program:
Exercised program is designed to take place three times a week for a total of eight weeks. Exercise intervention is scheduled for approximately 70 minutes per session (30 minutes of aerobic and 30 minutes of resistance, no break between two types, 5-min of preparation and 5-min relaxation stretching movements before and after each intervention), performed between 8:00 to 11:00 or between 14:00 to 16:30, Monday through Saturday.
Target heart rate during aerobic exercise is set as resting heart rate (HR) + 40%-70% of heart rate reserve (HRR). Participants' HRR was calculated based on their resting HR and maximum heart rate (HRmax=208-0.7×age) as HRmax - HR. Heart rate monitors (OH1, Polar Oy, Oulu, Finland) are used during all exercise sessions to track exercise intensity and ensure that it remained within the specified range. Aerobic exercise is performed on bicycle ergometers for a continuous 30 minutes with a progressive intensity of 40%-70% HRR. Resistance level is set according to an adaptive training prior to the first intervention, pedal cadences are 50-60r/min.
Resistance exercise is conducted using a set of equipment including chest press/ row, leg extension/ curl, abdominal/ back, biceps/ triceps, inner/ outer thigh, and push/ pull machines. Prior to conducting the 1 repetition maximum (RM) testing for the major muscles of the upper and lower limbs, all participants receive proper instructions on how to use the equipment. The Brzycki 1-RM prediction equation is used to estimate the 1RM based on the recorded resistance and repetitions. All participants performe resistance exercise with a weight of 60%-80% 1RM. Movements on each machine are repeated 10-12 times per unit for a total of 4 units, with a-30 second break between units.
In all intervention sessions, participants in AR group complete aerobic exercise before starting resistance exercise, while participants in RA group performe two types of exercise in a reversed order. Participants are instructed to maintain their usual lifestyle but refrain from engaging in other forms of regular exercise throughout the intervention period.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| AR group | Experimental | Behavioral: AR group: aerobic training before resistance trainingaerobic exercise then resistance exercise in all training sessions |
| RA group | Active comparator | Behavioral: RA group: resistance exercise before aerobic exerciseresistance exercise then aerobic exercise in all training sessions |
Who may qualify
- Ages
- 50 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age 50-70 years;
- Type 2 diabetes diagnosed as: random blood glucose ≥11.1mmol/L (200mg/dL) or fasting blood glucose ≥7.0mmol/L (126mg/L) or oral glucose tolerance test (2h) ≥11.1mmol/L (200mg/dL) or glycated hemoglobin (HbA1c) ≥ 6.5%;
- The course of type 2 diabetes lasted for one year or longer;
- Willing to participate and sign the informed consent form voluntarily
Key exclusion criteria (10 listed)
- Type 1 diabetes;
- Fasting blood glucose (FBG)>16.7mmol/L;
- Severe complications of diabetes such as acute infection, diabetic ketoacidosis, and plantar lesions;
- Severe kidney disease, cardiovascular and cerebrovascular diseases as identified by a specialist;
- Musculoskeletal, neurological, psychiatric or other disorders which limit the ability to exercise as identified by a specialist;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AR group: aerobic training before resistance trainingExercise are performed 3 times/wk for 8 wks. Aerobic training sessions are performed using cycle ergometers. Riding speed is 55-60 rotations/min, at an intensity between 50%-75% of heart rate reserve (HRR). Real-time heart rate monitors are worn by each participant during the session. Aerobic training session lasts for 30 minutes, with an additional 5-minute warm-up and 5-min relaxation training before and after the session, respectively. Participants perform resistance exercise on a set of strength training equipment. Load of resistance exercise is between 60-80% of repetition maximum (RM) in each set of exercise. Six different groups of resistance exercise (involving contractions and relaxations of biceps, triceps, pectoralis major, latissimus dorsi, quadriceps, and hamstrings) are conducted, with 6 sets of 10 repeated tasks in each group. Participants are instructed to finish each set of exercise task within 60 seconds. Between each two sets, there are 60 s of rest time. | Behavioural | AR group |
| RA group: resistance exercise before aerobic exerciseExercise are performed 3 times/wk for 8 wks. Following a 5-min warm-up exercise, the participants perform resistance training on a set of equipment. Load of resistance exercise is set between 60-80% of repetition maximum in each set of exercise. Six different groups of resistance exercise (involving contractions and relaxations of biceps, triceps, pectoralis major, latissimus dorsi, quadriceps, and hamstrings) are conducted, with 6 sets of 10 repeated tasks in each group. Participants are instructed to finish each set of exercise task within 60 s. Between each two sets, there are 60 seconds of rest time. Aerobic training sessions are performed using cycle ergometers. Riding speed is 55-60 rotations/min, at an intensity between 50%-75% of heart rate reserve. Real-time heart rate monitors are worn during the entire session. Each aerobic training session lasts for 30 minutes, with an 5-minute relaxation training after the session. | Behavioural | RA group |
Primary outcome
Fasting Glucose at Baseline
Time frame: At week 0, within 7 days before the intervention starts
blood glucose level following overnight (12-h) fasting
Fasting Glucose at Follow-up
Time frame: At week 9, within 7 days after the intervention completes
blood glucose level following overnight (12-h) fasting
Hemoglobin A1c (HbA1c) at Baseline
Time frame: At baseline, within 7 days before the intervention starts
At baseline, the HbA1c level in blood among all participants
Hemoglobin A1c (HbA1c) at Follow-up
Time frame: At week 9, within 7 days after the completion of the 8-week intervention
After intervention, the HbA1c level in blood among all participants
Continuous Glucose Monitoring at Baseline (Mean, sd, Lage)
Time frame: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (mean, sd, lage)
At baseline, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Continuous Glucose Monitoring at Baseline (Coefficient of Variation)
Time frame: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (cv)
At baseline, 14-day continuous glucose monitoring including mean glucose value, standard deviation (SD) of the glucose values, coefficient of variation (CV) of relative standard deviation, LAGE, TIR, TAR, TBR
Continuous Glucose Monitoring at Baseline (Tir, Tar, Tbr)
Time frame: At baseline, within 14 days before the intervention starts, measurement lasts for 14 days (tir, tar, tbr)
At baseline, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Continuous Glucose Monitoring at Follow-up (Mean, sd, Lage)
Time frame: at week 8-9
After intervention, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Continuous Glucose Monitoring at Follow-up (Coefficient of Variation)
Time frame: at week 8-9
At baseline, 14-day continuous glucose monitoring including mean glucose value, standard deviation (SD) of the glucose values, coefficient of variation (CV) of relative standard deviation, LAGE, TIR, TAR, TBR
Continuous Glucose Monitoring at Follow-up (Tir, Tar, Tbr)
Time frame: at week 8-9
After intervention, 14-day continuous glucose monitoring including mean, sd, cv, lage, tir, tar, tbr
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Type 2 Diabetes
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yan Zhao, MD, PhD study director
Nanjing Sport Institute
Xiao Tan, PhD principal investigator
Zhejiang University
Lijun Wei, MD study director
Maigaoqiao Community Health Service Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AR group: aerobic training before resistance training and RA group: resistance exercise before aerobic exercise in people with Type 2 Diabetes, run by Zhejiang University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 3 Apr 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fasting Glucose at Baseline (time frame: At week 0, within 7 days before the intervention starts). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2025.